
100ANNUAL REPORT 2022
SHAREHOLDER INFORMATION
During 2022, the share price moved from NOK 23.60 to NOK
28.05, an increase of 18.9 per cent. In addition, in 2022, the
company paid an ordinary dividend of NOK 0.25 per share
The Oslo Børs Main Index decreased by 1 per cent during
the same period. The share price has varied between NOK
16.94 and NOK 28.35. At the end of 2022, the company’s
market capitalisation was NOK 5545.2 million. A total of 93.4
million shares were traded during the year, corresponding to
a turnover rate of 47,3 per cent.
Shareholder structure
At the end of 2022, Kitron had 9 026 shareholders, compared
with 9 010 shareholders at the end of 2021. At the end of the
year, the foreign shareholding amounted to 27.4 per cent.
compared to with 27.9 per cent at the end of 2021.
At the balance sheet date, Folketrygdfondet was the largest
shareholder, holding 8.79 per cent of the Kitron shares,
followed Verdipapirfonden Odin Norge with 6.72 per cent and
Vevlen Gård AS with 6.32 per cent. The liquidity of the share
was 100 per cent. The 20 largest shareholders held a total
of 59.43 per cent of the company’s shares at the end of the
year.
Mandates
Authorization to the board to issue shares
The ordinary general meeting of 28 April 2022 authorized the
board of directors of Kitron ASA to increase the share capital
in accordance with the Norwegian Public Limited Liability
Companies Act section 10-14 on the following conditions:
Authorization to strengthen equity and incentive
schemes
The share capital may, in one or more rounds, in total be
increased with up to NOK 1,970,143.90.
The Board of Directors may not use the authorization if the
total increase of the share capital approved by the Board
of Directors in accordance with this authorization together
with the use of other authorizations to issue shares, in the
period for the authorization, exceeds NOK 3,940,287.80. The
authorization shall be valid until the Annual General Meeting
in 2023, but no later than 30 June 2023. The shareholders’
pre-emptive rights according to the Norwegian Public
Limited Liability Companies Act section 10-4 may be set
aside. The authorization is not intended for use to facilitate
or obstruct the success of a take-over bid where Kitron
is the target company. The authorization encompasses
share capital increase by contribution in any kind and the
right to incur Kitron ASA with special obligations according
to the Norwegian Public Limited Liability Companies Act
section 10-2. The authorization encompasses resolutions
on merger according to the Norwegian Public Limited
Liability Companies Act section 13-5. The authorization is
limited to encompass capital requirements or issuance of
consideration shares in relation to strengthening of Kitron
ASA’s equity, joint ventures or joint business operations,
remuneration to members of the Board of Directors of Kitron
ASA, incentive schemes, and acquisition of property and
business within Kitron ASA’s purpose. The Board of Directors
is authorized to decide other terms and conditions of the
subscription and is authorized to amend the articles of
association as implied by the use of this authorization. This
authorization replaces any previously granted authorizations
for the Board of Directors to increase the share capital. The
authorization was used by the board in 2022 to increase
share capital by NOK 67 666,40 to NOK 19 769 105,30.
Strategic authorization
The share capital may, in one or more rounds, in total
be increased with up to NOK 3,940,287.80. The Board of
Directors may not use the authorization if the total increase
of the share capital approved by the Board of Directors in
accordance with this authorization together with the use of
other authorizations to issue shares, in the period for the
authorization, exceeds NOK 3,940,287.80. The authorization
shall be valid until the Annual General Meeting in 2023,
but no later than 30 June 2023. The shareholders’ pre-
emptive rights according to the Norwegian Public Limited
Liability Companies Act section 10-4 may be set aside.
The authorization is not intended for use to facilitate or
obstruct the success of a take-over bid where Kitron is the
target company. The authorization encompasses share
capital increase by contribution in any kind and the right to
incur Kitron ASA with special obligations according to the
Norwegian Public Limited Liability Companies Act section
10-2. The authorization encompasses resolutions on
merger according to the Norwegian Public Limited Liability
Companies Act section 13-5. The authorization is limited to
include strengthening of Kitron ASA’s equity and issuing of
consideration shares in connection with acquisition of other
companies or enterprises within Kitron ASA’s purpose. The
Board of Directors is authorized to decide other terms and
conditions of the subscription and is authorized to amend
the articles of association as implied by the use of this
authorization. This authorisation was not used by the board
in 2022.
Authorization to the board to buy own shares
The ordinary general meeting on 27 April 2022 authorized
the board of directors of Kitron ASA to acquire Kitron ASA’s
own shares, for the purpose of ownership or charge, in
accordance with the Norwegian Public Limited Liability
Companies Act sections 9-4 and 9-5 on the following
conditions:
The Board of Directors may acquire shares in Kitron ASA, on
one or several occasions, provided that the total combined
nominal value of the acquired shares after the acquisition